New York State Teachers Retirement System Boosts Stock Holdings in Solventum Co. (NYSE:SOLV)

New York State Teachers Retirement System lifted its position in Solventum Co. (NYSE:SOLV - Free Report) by 4.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 124,699 shares of the company's stock after purchasing an additional 4,819 shares during the quarter. New York State Teachers Retirement System owned about 0.07% of Solventum worth $8,238,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Trian Fund Management L.P. increased its holdings in shares of Solventum by 32.9% during the 3rd quarter. Trian Fund Management L.P. now owns 7,126,255 shares of the company's stock worth $496,842,000 after buying an additional 1,765,676 shares during the last quarter. State Street Corp grew its position in Solventum by 3.1% in the third quarter. State Street Corp now owns 6,107,550 shares of the company's stock worth $425,818,000 after acquiring an additional 185,938 shares during the period. Geode Capital Management LLC increased its stake in Solventum by 4.0% during the third quarter. Geode Capital Management LLC now owns 3,347,719 shares of the company's stock worth $232,608,000 after acquiring an additional 128,317 shares during the last quarter. Hotchkis & Wiley Capital Management LLC purchased a new stake in Solventum in the third quarter valued at $125,488,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Solventum by 0.4% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,053,771 shares of the company's stock valued at $73,469,000 after purchasing an additional 3,745 shares during the last quarter.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Morgan Stanley raised their price objective on Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a research report on Monday, November 11th. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $70.00 price target on the stock. Finally, Piper Sandler lifted their target price on shares of Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $68.29.

Solventum Trading Down 1.9 %

Shares of SOLV stock traded down $1.42 during trading hours on Friday, hitting $73.08. The stock had a trading volume of 570,685 shares, compared to its average volume of 891,579. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The stock's 50 day moving average is $71.07 and its 200 day moving average is $68.95. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.